An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma

SIMPLE SUMMARY: Glioblastoma is a devastating malignancy that has continued to prove resistant to a variety of therapeutics. No new systemic therapy has been approved for use against glioblastoma in almost two decades. This observation is particularly disturbing given the amount of money invested in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyne, Seán B., Yamini, Bakhtiar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073966/
https://www.ncbi.nlm.nih.gov/pubmed/33919596
http://dx.doi.org/10.3390/cancers13081953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073966/
https://www.ncbi.nlm.nih.gov/pubmed/33919596
http://dx.doi.org/10.3390/cancers13081953

Ejemplares similares